LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

Veru Inc

Затворен

0.51 2

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

0.49

Максимум

0.53

Ключови измерители

By Trading Economics

Приходи

-415K

-8.9M

EPS

-0.071

Марж на печалбата

-128.154

Служители

210

EBITDA

-2.4M

-10M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+700% upside

Дивиденти

By Dow Jones

Следващи печалби

7.08.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

75M

Предишно отваряне

-1.49

Предишно затваряне

0.51

Техническа оценка

By Trading Central

Увереност

Weak Bearish Evidence

Veru Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

12.05.2025 г., 22:34 ч. UTC

Придобивния, сливания и поглъщания

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12.05.2025 г., 23:48 ч. UTC

Пазарно говорене

Gold Edges Higher on Possible Technical Recovery -- Market Talk

12.05.2025 г., 23:46 ч. UTC

Пазарно говорене

Nikkei Likely to Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

12.05.2025 г., 23:34 ч. UTC

Пазарно говорене

Trade Deal Lowers US Recession Risks to 35% -- Market Talk

12.05.2025 г., 23:21 ч. UTC

Пазарно говорене

US-China Trade Deal Still Risks Stagflation; Supply Chain Disruption -- Market Talk

12.05.2025 г., 22:54 ч. UTC

Пазарно говорене

Australian Treasurer Warns Uncertainty Will Still Dominate Markets -- Market Talk

12.05.2025 г., 22:43 ч. UTC

Печалби

Telefonica Brasil 1Q EPS BRL0.65 >VIV

12.05.2025 г., 22:14 ч. UTC

Топ новини

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

12.05.2025 г., 22:08 ч. UTC

Придобивния, сливания и поглъщания

Ampol Expects Replacement-Cost Ebitda Uplift by Run Rate at End-2025 of Around A$30 Million/Year

12.05.2025 г., 22:08 ч. UTC

Придобивния, сливания и поглъщания

Ampol Expects Pretax Proceeds of Around A$65 Million From Transactions

12.05.2025 г., 22:07 ч. UTC

Придобивния, сливания и поглъщания

Ampol to Sell Australia Retail Electricity Business for Nominal Sum

12.05.2025 г., 22:07 ч. UTC

Придобивния, сливания и поглъщания

Ampol to Sell Australia Retail Electricity Business to AGL

12.05.2025 г., 22:06 ч. UTC

Придобивния, сливания и поглъщания

Meridian to Take on Flick, Z Energy Branded Electricity Customers

12.05.2025 г., 22:06 ч. UTC

Придобивния, сливания и поглъщания

Meridian Energy to Buy Business From Ampol for NZ$70 Million

12.05.2025 г., 22:05 ч. UTC

Придобивния, сливания и поглъщания

Ampol to Sell New Zealand Electricity Retailing Businesses to Meridian Energy

12.05.2025 г., 22:04 ч. UTC

Придобивния, сливания и поглъщания

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12.05.2025 г., 21:15 ч. UTC

Топ новини

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- 2nd update -- WSJ

12.05.2025 г., 21:01 ч. UTC

Печалби

Constellation Software 1Q Rev $2.65B >CSU.T

12.05.2025 г., 21:01 ч. UTC

Печалби

Constellation Software 1Q Net $115M >CSU.T

12.05.2025 г., 21:01 ч. UTC

Печалби

Constellation Software 1Q EPS $5.44 >CSU.T

12.05.2025 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

12.05.2025 г., 20:50 ч. UTC

Пазарно говорене
Печалби

Basic Materials Roundup: Market Talk

12.05.2025 г., 20:44 ч. UTC

Топ новини

Trade Thaw Sparks Stock Rally, Leaves Wall Street Cautious -- WSJ

12.05.2025 г., 20:31 ч. UTC

Топ новини

How to Think About the Stock Market When Earnings Guidance Becomes Meaningless -- Heard on the Street -- UPDATED -- WSJ

12.05.2025 г., 20:24 ч. UTC

Печалби

Energy Vault Holdings: Encouraging News on China/U.S. Tariff Pause, Pending Final Positive Resolution and Timing >NRGV

12.05.2025 г., 20:24 ч. UTC

Печалби

Energy Vault Holdings: No Change to Current Guidance, With Potential Rev Upside on Accelerated U.S. Battery Deliveries in 2025 >NRGV

12.05.2025 г., 20:24 ч. UTC

Топ новини

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- WSJ

12.05.2025 г., 20:22 ч. UTC

Придобивния, сливания и поглъщания

Spirit AeroSystems Holdings: IRS Rules That Sale to Boeing Will Qualify as a Reorganization Under Section 368(a)(1)(B)

12.05.2025 г., 20:15 ч. UTC

Печалби

Rigetti Computing Reports Earnings. How the Company Takes a Different Approach to Quantum. -- Barrons.com

12.05.2025 г., 20:10 ч. UTC

Печалби

Blink Charging 1Q Rev $20.8M >BLNK

Сравнение с други в отрасъла

Ценова промяна

Veru Inc Прогноза

Ценова цел

By TipRanks

700% нагоре

12-месечна прогноза

Среден 4 USD  700%

Висок 4 USD

Нисък 4 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Veru Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

1

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

0.5101 / 0.5239Подкрепа & съпротива

Краткосрочен план

Weak Bearish Evidence

Средносрочен план

Strong Bearish Evidence

Дългосрочен план

Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Veru Inc

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.